NRZ — Neurizer Income Statement
0.000.00%
Last trade - 00:00
- AU$4.11m
- AU$3.70m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.124 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | -4.26 | — | — | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.5 | 7.03 | 8.86 | 12.5 | 12.6 |
Operating Profit | -7.37 | -7.03 | -8.86 | -12.5 | -12.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.53 | -7.15 | -13.6 | -20.4 | -16.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.53 | -7.15 | -13.6 | -20.4 | -16.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -9.53 | -7.15 | -13.6 | -20.4 | -16.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.53 | -7.15 | -13.6 | -20.4 | -16.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.022 | -0.013 | -0.021 | -0.025 | -0.017 |